ro5024048
Showing 1 - 11 of 11
Healthy Volunteer Trial in Orlando, Knoxville, Christchurch (RO5024048)
Completed
- Healthy Volunteer
- RO5024048
-
Orlando, Florida
- +2 more
Nov 1, 2016
Healthy Volunteer Trial in Glendale, Eatontown (Placebo, RO5024048)
Completed
- Healthy Volunteer
- Placebo
- RO5024048
-
Glendale, California
- +1 more
Nov 1, 2016
Hepatitis C, Chronic Trial (RO5024048, danoprevir, peginterferon alfa-2a [Pegasys])
Withdrawn
- Hepatitis C, Chronic
- RO5024048
- +4 more
- (no location specified)
Nov 1, 2016
Hepatitis C, Chronic Trial in Worldwide (RO5024048, RO5190591, RO5466731)
Completed
- Hepatitis C, Chronic
- RO5024048
- +4 more
-
LaJolla, California
- +30 more
Nov 1, 2016
Hepatitis C, Chronic Trial in Worldwide (Copegus , RO5024048, danoprevir)
Completed
- Hepatitis C, Chronic
- Copegus placebo
- +5 more
-
La Jolla, California
- +31 more
Nov 1, 2016
Hepatitis C, Chronic Trial in Canada, United States (RO5024048, Ribavirin [Copegus], peginterferon alfa-2a [Pegasys])
Completed
- Hepatitis C, Chronic
- RO5024048
- +2 more
-
La Jolla, California
- +24 more
Nov 1, 2016
Hepatitis C, Chronic Trial in Worldwide (RO5024048, danoprevir, peginterferon alfa-2a [Pegasys])
Completed
- Hepatitis C, Chronic
- RO5024048
- +4 more
-
Birmingham, Alabama
- +26 more
Jul 28, 2016
Healthy Volunteers, Hepatitis C Virus Trial in New Zealand, Puerto Rico, United States (RO5024048)
Completed
- Healthy Volunteers
- Hepatitis C Virus
- RO5024048
-
San Francisco, California
- +8 more
Apr 23, 2009